Alzheimers Drug Discovery Foundation
- Assets
- $340.3m
- Revenue
- $254.0m
- Investments
- $0.0
- Employees
- 41
- Location
- New York, NY
- Founding
- 09/2005
- Data as of
- 12/2022
- EIN
- 20-1082179
Organization Overview
Alzheimers Drug Discovery Foundation is located in New York, NY. The organization was established in 2005. According to its NTEE Classification (V36) the organization is classified as: Gerontology, under the broad grouping of Social Science and related organizations. As of 12/2022, Alzheimers Drug Discovery Foundation employed 41 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alzheimers Drug Discovery Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Alzheimers Drug Discovery Foundation generated $254.0m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 40.9% each year . All expenses for the organization totaled $36.8m during the year ending 12/2022. While expenses have increased by 11.7% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Alzheimers Drug Discovery Foundation has awarded 189 individual grants totaling $140,433,708. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION IS DEDICATED TO RAPIDLY ACCELERATING THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. THE ADDF IS SOLELY FOCUSED ON FUNDING THE DEVELOPMENT OF DRUGS FOR ALZHEIMER'S, EMPLOYING A VENTURE PHILANTHROPY MODEL TO SUPPORT RESEARCH IN ACADEMIA AND THE BIOTECH INDUSTRY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Alice Shure Governor | Trustee | 1 | $0 |
Beatriz Illescas Putzeys-Claugus Governor | Trustee | 1 | $0 |
Bonnie Pfeifer Evans Governor | Trustee | 1 | $0 |
David Weinreb Governor | Trustee | 1 | $0 |
Gary M Lauder Governor | Trustee | 1 | $0 |
Howard Fillit MD Founding Exec Dir And Chief Science Officer | OfficerTrustee | 40 | $593,893 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Allan M Green Md Phd Jd Legal Services | 12/30/22 | $132,600 |
Morgan Lewis & Bockius Llp Legal Services | 12/30/22 | $656,670 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $5,585,228 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $244,256,775 |
| Noncash contributions included in lines 1a–1f | $14,190,352 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $249,842,003 |
| Total Program Service Revenue | $6,425,669 |
| Investment income | $857,675 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$2,911,987 |
| Net Income from Fundraising Events | -$186,255 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $254,027,105 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $21,302,149 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $8,153,772 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,873,002 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,421,825 |
| Pension plan accruals and contributions | $198,235 |
| Other employee benefits | $278,464 |
| Payroll taxes | $218,907 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $861,428 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $259,895 |
| Advertising and promotion | $0 |
| Office expenses | $197,293 |
| Information technology | $197,861 |
| Royalties | $0 |
| Occupancy | $567,218 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $527,708 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $79,599 |
| Total functional expenses | $36,842,901 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,660,731 |
| Savings and temporary cash investments | $45,203,944 |
| Pledges and grants receivable | $213,144,667 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $270,603 |
| Net Land, buildings, and equipment | $160,061 |
| Investments—publicly traded securities | $77,192,847 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $2,620,988 |
| Total assets | $340,253,841 |
| Accounts payable and accrued expenses | $2,594,953 |
| Grants payable | $50,849,708 |
| Deferred revenue | $637,024 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $2,659,982 |
| Total liabilities | $56,741,667 |
| Net assets without donor restrictions | $61,551,323 |
| Net assets with donor restrictions | $221,960,851 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $340,253,841 |
Grants Awarded
Over the last fiscal year, Alzheimers Drug Discovery Foundation has awarded $21,272,540 in support to 18 organizations.
| Grant Recipient | Amount |
|---|---|
ACURASTEM INCORPORATED PURPOSE: ALZHEIMERS RESEARCH | $2,927,453 |
CICARDIC LLC PURPOSE: ALZHEIMERS RESEARCH | $221,400 |
COGNITO THERAPEUTICS PURPOSE: ALZHEIMERS RESEARCH | $4,556,150 |
DIGITAL MEDICINE SOCIETY (DIME) PURPOSE: ALZHEIMERS RESEARCH | $210,000 |
EMORY UNIVERSITY PURPOSE: ALZHEIMERS RESEARCH | $61,950 |
LEXEO THERAPEUTICS INC PURPOSE: ALZHEIMERS RESEARCH | $20,529 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Ithaka Harbors Inc New York, NY | $306,195,341 | $115,151,783 |
Global Poverty Project Inc New York, NY | $17,659,353 | $56,462,217 |
National Bureau Of Economic Research Inc Cambridge, MA | $176,832,918 | $41,671,966 |
Alzheimers Drug Discovery Foundation New York, NY | $340,253,841 | $254,027,105 |
African Population Health & Research Center Inc Rockville, MD | $56,895,501 | $31,580,835 |
Social Science Research Council Brooklyn, NY | $63,899,235 | $32,941,125 |